BioNeutra Global Corporation (BGACF)
| Market Cap | 1.01M -70.1% |
| Revenue (ttm) | 8.04M -3.6% |
| Net Income | -451.69K |
| EPS | -0.01 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 313 |
| Open | 0.0056 |
| Previous Close | 0.0670 |
| Day's Range | 0.0056 - 0.0056 |
| 52-Week Range | 0.0056 - 0.0670 |
| Beta | 1.01 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 4, 2026 |
About BioNeutra Global
BioNeutra Global Corporation engages in the research and development, production, and commercialization of food for nutraceutical, functional, and mainstream food and beverage products with a focus on oligosaccharides. The company offers isomalt oligosaccharide ingredients under the VitaFiber brand for human digestive health. It operates in Canada, the United States, Australia, New Zealand, European Union, and the Asia Pacific. The company is headquartered in Vancouver, Canada. [Read more]
Financial Performance
In 2023, BioNeutra Global's revenue was 11.38 million, a decrease of -15.00% compared to the previous year's 13.39 million. Losses were -2.11 million, -27.86% less than in 2022.
Financial numbers in CAD Financial StatementsNews
BioNeutra Board Changes
Vancouver, British Columbia – (October 1 7 , 2025) – TheNewswire - BioNeutra Global Corporation (“BioNeutra” or the “Company”) (TSXV: BGA; OTC Pink : BGACF) announces that Mr. Bill Smith has resigned ...